Is Enanta Pharmaceuticals, Inc. (ENTA) a Buy, Sell, or Hold?
NASDAQ : ENTA
Enanta Pharmaceuticals, Inc. — Analyst Ratings
$13.77 USD
$0.43 (3.22%)
- Volume
- 182.99K
- Average Volume
- 171.4K
- Market Capitalization
- $400.41M
- P/E Ratio
- -5.03
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $17.15
- Year Low
- $6.45
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.84
Analyst Consensus Summary
Consensus Rating
Strong Sell
19 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-31.2%
vs Current Price
Price Target
$20.00
Average TargetPrice Target Range
Lowest Target
$20.00
-31.2% DOWNSIDE
Average Target
$20.00
Median Estimate
Highest Target
$20.00
-31.2% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 19
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 14 | 3 | 2 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Brandon Folkes | $20 | $13.37 | 2026-06-23 06:52 AM | 49.6% |
| Jefferies | Akash Tewari | $20 | $10.8849 | 2025-10-01 10:21 AM | 83.7% |
| JMP Securities | Roy Buchanan | $24 | $7.19 | 2025-06-03 05:37 AM | 233.8% |
| Piper Sandler | Yasmeen Rahimi | $87 | $51.275 | 2022-07-29 06:32 AM | 69.7% |